fourteenth meeting parties decided dec xiv noting transition chlorofluorocarbon free cfc free alternative treatments asthma chronic obstructive pulmonary disease copd depends largely non article parties adopting effective transition strategies cfc metered dose inhaler manufacturers diligently developing seeking approval for launching cfc free metered dose inhalers dry powder inhalers noting concern slow transition cfc free metered dose inhalers parties need affordable available alternatives parties operating article recognizing desirability transparent presentation data assist parties better understanding essential use cfc volumes gauging progress on impediments to transition request party regional economic integration organization submit available information ozone secretariat february annual updates thereafter following information concerning inhaler treatments asthma copd contain cfcs contain cfcs cfc non cfc metered dose inhalers dry powder inhalers sold distributed within party active ingredient brand manufacturer source import domestic production cfc non cfc metered dose inhalers dry powder inhalers produced within party export parties active ingredient brand manufacturer source importing party non cfc metered dose inhalers dry powder inhalers date approved authorized marketing and or launched territory party request technology economic assessment panel take account information submitted pursuant paragraph available information annual assessment request parties pay due consideration information reviewing national transition strategies